Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
LMFA03010021 15d PGJ2 cPLA2i 1.0 BCD110605C28 0.071 pmol/ml medium
LMFA03010021 15d PGJ2 cPLA2i 1.0 BCD110605C30 0.121 pmol/ml medium
LMFA03010021 15d PGJ2 cPLA2i 1.0 BCD110605C29 0.064 pmol/ml medium
LMFA03010021 15d PGJ2 cPLA2i 20.0 BCD110605C64 0.071 pmol/ml medium
LMFA03010021 15d PGJ2 cPLA2i 20.0 BCD110605C66 0.057 pmol/ml medium
LMFA03010021 15d PGJ2 cPLA2i 20.0 BCD110605C65 0.072 pmol/ml medium
LMFA03010021 15d PGJ2 PLDi 1.0 BCD110605C16 0.079 pmol/ml medium
LMFA03010021 15d PGJ2 PLDi 1.0 BCD110605C17 0.076 pmol/ml medium
LMFA03010021 15d PGJ2 PLDi 1.0 BCD110605C18 0.047 pmol/ml medium
LMFA03010021 15d PGJ2 PLDi 20.0 BCD110605C54 0.08 pmol/ml medium
LMFA03010021 15d PGJ2 PLDi 20.0 BCD110605C52 0.082 pmol/ml medium
LMFA03010021 15d PGJ2 PLDi 20.0 BCD110605C53 0.093 pmol/ml medium
LMFA03010021 15d PGJ2 KDO+cPLA2i 1.0 BCD110605C32 0.102 pmol/ml medium
LMFA03010021 15d PGJ2 KDO+cPLA2i 1.0 BCD110605C31 0.116 pmol/ml medium
LMFA03010021 15d PGJ2 KDO+cPLA2i 1.0 BCD110605C33 0.095 pmol/ml medium
LMFA03010021 15d PGJ2 KDO+cPLA2i 20.0 BCD110605C68 0.134 pmol/ml medium
LMFA03010021 15d PGJ2 KDO+cPLA2i 20.0 BCD110605C69 0.165 pmol/ml medium
LMFA03010021 15d PGJ2 KDO+cPLA2i 20.0 BCD110605C67 0.15 pmol/ml medium
LMFA03010021 15d PGJ2 KDO+PLDi 1.0 BCD110605C19 0.09 pmol/ml medium
LMFA03010021 15d PGJ2 KDO+PLDi 1.0 BCD110605C20 0.065 pmol/ml medium
LMFA03010021 15d PGJ2 KDO+PLDi 1.0 BCD110605C21 0.088 pmol/ml medium
LMFA03010021 15d PGJ2 KDO+PLDi 20.0 BCD110605C56 0.206 pmol/ml medium
LMFA03010021 15d PGJ2 KDO+PLDi 20.0 BCD110605C57 0.214 pmol/ml medium
LMFA03010021 15d PGJ2 KDO+PLDi 20.0 BCD110605C55 0.178 pmol/ml medium
LMFA03010021 15d PGJ2 KDO+ATP+cPLA2i 1.0 BCD110605C37 0.067 pmol/ml medium
LMFA03010021 15d PGJ2 KDO+ATP+cPLA2i 1.0 BCD110605C38 0.074 pmol/ml medium
LMFA03010021 15d PGJ2 KDO+ATP+cPLA2i 1.0 BCD110605C39 0.083 pmol/ml medium
LMFA03010021 15d PGJ2 KDO+ATP+cPLA2i 20.0 BCD110605C74 0.261 pmol/ml medium
LMFA03010021 15d PGJ2 KDO+ATP+cPLA2i 20.0 BCD110605C75 0.246 pmol/ml medium
LMFA03010021 15d PGJ2 KDO+ATP+cPLA2i 20.0 BCD110605C73 0.27 pmol/ml medium
LMFA03010021 15d PGJ2 KDO+ATP+PLDi 1.0 BCD110605C25 0.077 pmol/ml medium
LMFA03010021 15d PGJ2 KDO+ATP+PLDi 1.0 BCD110605C27 0.063 pmol/ml medium
LMFA03010021 15d PGJ2 KDO+ATP+PLDi 1.0 BCD110605C26 0.068 pmol/ml medium
LMFA03010021 15d PGJ2 KDO+ATP+PLDi 20.0 BCD110605C61 0.712 pmol/ml medium
LMFA03010021 15d PGJ2 KDO+ATP+PLDi 20.0 BCD110605C62 0.823 pmol/ml medium
LMFA03010021 15d PGJ2 KDO+ATP+PLDi 20.0 BCD110605C63 0.75 pmol/ml medium
LMFA03010021 15d PGJ2 KDO + ATP 1.0 BCD110605C15 0.074 pmol/ml medium
LMFA03010021 15d PGJ2 KDO + ATP 1.0 BCD110605C14 0.059 pmol/ml medium
LMFA03010021 15d PGJ2 KDO + ATP 1.0 BCD110605C13 0.058 pmol/ml medium
LMFA03010021 15d PGJ2 KDO + ATP 20.0 BCD110605C49 0.831 pmol/ml medium
LMFA03010021 15d PGJ2 KDO + ATP 20.0 BCD110605C50 0.892 pmol/ml medium
LMFA03010021 15d PGJ2 KDO + ATP 20.0 BCD110605C51 0.892 pmol/ml medium
LMFA03010021 15d PGJ2 KDO 1.0 BCD110605C08 0.071 pmol/ml medium
LMFA03010021 15d PGJ2 KDO 1.0 BCD110605C07 0.093 pmol/ml medium
LMFA03010021 15d PGJ2 KDO 1.0 BCD110605C09 0.065 pmol/ml medium
LMFA03010021 15d PGJ2 KDO 20.0 BCD110605C45 0.227 pmol/ml medium
LMFA03010021 15d PGJ2 KDO 20.0 BCD110605C44 0.234 pmol/ml medium
LMFA03010021 15d PGJ2 KDO 20.0 BCD110605C43 0.243 pmol/ml medium
LMFA03010021 15d PGJ2 C 0.0 BCD110605C03 0.166 pmol/ml medium
LMFA03010021 15d PGJ2 C 0.0 BCD110605C01 0.103 pmol/ml medium